Viewing Study NCT01547260


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-07-12 @ 5:02 PM
Study NCT ID: NCT01547260
Status: COMPLETED
Last Update Posted: 2022-08-22
First Post: 2012-02-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
Sponsor: Maria Liljefors
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pancreatic Carcinoma Metastatic View
None Pancreatic Ductal Adenocarcinoma View
Keywords: